Fluticasone-salmeterol 230-21 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26FA1R7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,869
Award facts
- Contract value 100% obligated
- $18,868.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,868.95 to AmerSourceBergen Drug Corp for the supply of Fluticasone-Salmeterol 230-21 12GM, a combination respiratory medication used for asthma and chronic obstructive pulmonary disease management. The contract was competitively awarded without set-aside provisions on January 7, 2026, with a firm fixed-price structure and an ultimate completion date of January 8, 2026. Performance will be conducted at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 31, 2031.
AmerSourceBergen Drug Corp functions as a critical pharmaceutical distributor supporting military healthcare systems and federal medical procurement needs through the Defense Logistics Agency's Medical Supply Chain. The parent company Cencora, Inc., registered in the System for Award Management since 2015, maintains significant contract vehicles with the DLA and Department of Justice Federal Bureau of Investigation, supplying a diverse portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to military treatment facilities and veterans' healthcare programs nationwide.
Quick answers
Who was awarded contract SPE2DR26FA1R7?
SPE2DR26FA1R7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FA1R7 worth?
The government has obligated $18,869 on SPE2DR26FA1R7.
Is contract SPE2DR26FA1R7 an order under another contract?
Yes. SPE2DR26FA1R7 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1R7 competed?
The extent of competition for SPE2DR26FA1R7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award